ArticleFrontiers in endocrinology2026

Empagliflozin attenuates AGE-BSA/high-glucose-induced inflammation in C2C12 myotubes associated with suppression of the RAGE/NF-κB pathway.

Xiaoying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.